Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.
OriginalsprogEngelsk
TidsskriftJ A M A: The Journal of the American Medical Association
Vol/bind308
Udgave nummer9
Sider (fra-til)882-9
Antal sider8
ISSN0098-7484
DOI
StatusUdgivet - 2012

ID: 48453205